CAS 1637300-25-4

AF64394

CAS: 1637300-25-4

AF64394

Fórmula: C₂₁H₂₀ClN₅O

Pureza: ≥95%

Peso molecular: 393.87

Ref: 54-BUP04518

AF64394

CAS: 1637300-25-4

Fórmula: C₂₁H₂₀ClN₅O

Pureza: 98%

Forma y color: Solid

Peso molecular: 393.8694

Ref: IN-DA01EO2Y

AF64394

CAS: 1637300-25-4

AF64394 is a selective inverse agonist of GPR3(pIC50 : 7.3)

Fórmula: C₂₁H₂₀ClN₅O

Pureza: 97.22%

Forma y color: Solid

Peso molecular: 393.87

Ref: TM-T8407

AF64394

CAS: 1637300-25-4

N-(4-Chloro-2-isopropoxybenzyl)-5-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

Fórmula: C₂₁H₂₀ClN₅O

Pureza: 98%

Peso molecular: 393.87

Ref: IN-DG00808356

AF64394

CAS: 1637300-25-4

AF64394 is a drug that has been shown to bind to cannabinoid receptors. It was initially discovered by observing its ability to inhibit the growth of cultured human cancer cells. AF64394 is a triazole derivative that has been shown in simulations and experiments with micelles to bind preferentially to the CB1 receptor in the brain, which is responsible for pain relief, mood changes, and appetite suppression. In addition, AF64394 has been shown to inhibit alzheimer's disease in mice by inhibiting acetylcholinesterase activity.

Fórmula: C₂₁H₂₀ClN₅O

Pureza: Min. 95%

Peso molecular: 393.87 g/mol

Ref: 3D-MQC30025